Korro Bio Inc.

17.88
0.44 (2.52%)
At close: Apr 25, 2025, 3:59 PM
17.64
-1.31%
Pre-market: Apr 28, 2025, 04:47 AM EDT
2.52%
Bid 16
Market Cap 167.83M
Revenue (ttm) 2.27M
Net Income (ttm) -83.58M
EPS (ttm) -9.37
PE Ratio (ttm) -1.91
Forward PE -1.49
Analyst Buy
Ask 18.27
Volume 38,927
Avg. Volume (20D) 90,608
Open 17.32
Previous Close 17.44
Day's Range 16.38 - 17.93
52-Week Range 11.13 - 98.00
Beta 2.31

About KRRO

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts....

Industry Biotechnology
Sector Healthcare
IPO Date Oct 3, 2019
Employees 104
Stock Exchange NASDAQ
Ticker Symbol KRRO
Full Company Profile

Analyst Forecast

According to 7 analyst ratings, the average rating for KRRO stock is "Buy." The 12-month stock price forecast is $120, which is an increase of 571.33% from the latest price.

Stock Forecasts

Next Earnings Release

Korro Bio Inc. is scheduled to release its earnings on May 13, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
+3.34%
Korro Bio shares are trading higher. HC Wainwright... Unlock content with Pro Subscription
5 months ago
-15.55%
Korro Bio shares are trading lower. The company reported Q3 financial results.